BRCA1andBRCA2 - update and implications on the genetics of breast cancer: a clinical perspective
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BRCA1andBRCA2 - update and implications on the genetics of breast cancer: a clinical perspective
Authors
Keywords
-
Journal
CLINICAL GENETICS
Volume 85, Issue 1, Pages 1-4
Publisher
Wiley
Online
2013-10-12
DOI
10.1111/cge.12291
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fallopian Tube Intraluminal Tumor Spread From Noninvasive Precursor Lesions
- (2013) Jonathan G. Bijron et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program
- (2013) Pål Møller et al. BREAST CANCER RESEARCH AND TREATMENT
- Ten-Year Survival in Patients With BRCA1-Negative and BRCA1-Positive Breast Cancer
- (2013) Tomasz Huzarski et al. JOURNAL OF CLINICAL ONCOLOGY
- GermlineBRCAMutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
- (2013) Elena Castro et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
- (2013) Nasim Mavaddat et al. JNCI-Journal of the National Cancer Institute
- Familial prostate cancer: the damage done and lessons learnt
- (2013) Nassim Taherian et al. Nature Reviews Urology
- Gene Patenting — The Supreme Court Finally Speaks
- (2013) Aaron S. Kesselheim et al. NEW ENGLAND JOURNAL OF MEDICINE
- The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
- (2012) J Iqbal et al. BRITISH JOURNAL OF CANCER
- Long-term results of screening with magnetic resonance imaging in women with BRCA mutations
- (2012) K Passaperuma et al. BRITISH JOURNAL OF CANCER
- Size surprise? Tumour size, nodal status, and outcome after breast cancer
- (2012) W.D. Foulkes Current Oncology
- BRCA, the Oviduct, and the Space and Time Continuum of Pelvic Serous Carcinogenesis
- (2012) Christopher P. Crum et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
- (2011) Z Kote-Jarai et al. BRITISH JOURNAL OF CANCER
- Prevalence ofBRCA1andBRCA2mutations in Ashkenazi Jewish families with breast and pancreatic cancer
- (2011) Zsofia K. Stadler et al. CANCER
- Complete remission, in BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma, treated with cisplatin based therapy
- (2011) Amir Sonnenblick et al. CANCER BIOLOGY & THERAPY
- Response to Neoadjuvant Systemic Therapy for Breast Cancer inBRCAMutation Carriers and Noncarriers: A Single-Institution Experience
- (2011) Banu Arun et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study
- (2010) Anita V. Mitra et al. BJU INTERNATIONAL
- Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
- (2010) Daniel P. Silver et al. JOURNAL OF CLINICAL ONCOLOGY
- BRCA1-Associated Breast Cancers Present Differently From BRCA2-Associated and Familial Cases: Long-Term Follow-Up of the Dutch MRISC Screening Study
- (2010) Adriana J. Rijnsburger et al. JOURNAL OF CLINICAL ONCOLOGY
- Family History of Cancer and Cancer Risks in Women with BRCA1 or BRCA2 Mutations
- (2010) K. Metcalfe et al. JNCI-Journal of the National Cancer Institute
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Tumor size and survival in breast cancer—a reappraisal
- (2010) William D. Foulkes et al. Nature Reviews Clinical Oncology
- Prolonged survival in a patient with BRCA2 associated metastatic pancreatic cancer after exposure to camptothecin: a case report and review of literature
- (2009) Edward James et al. ANTI-CANCER DRUGS
- Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy
- (2009) Tomasz Byrski et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
- (2008) T. Byrski et al. BREAST CANCER RESEARCH AND TREATMENT
- Rapid progression of prostate cancer in men with a BRCA2 mutation
- (2008) S A Narod et al. BRITISH JOURNAL OF CANCER
- A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations
- (2008) Ann K. Folkins et al. GYNECOLOGIC ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started